GlassScriptPhysician profile
Jeffrey Schwab
NPI 1609833813
$18,648.01
in general payments reported to CMS, 2019-2025
30 companies · $1,930 in 2025
The $1,930 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,444 · 2020: $151 · 2021: $221 · 2022: $9,058 · 2023: $1,703 · 2024: $140 · 2025: $1,930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,920 · Education: $1,068 · Travel and Lodging: $768 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,920.37 |
| Education | $1,068.49 |
| Travel and Lodging | $768.29 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,008.08 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $424.41 | 2022-2025 | Bis |
| Davol INC. | $209.13 | 2019-2025 | Phasix Mesh |
| Covidien LP | $191.09 | 2019 | |
| Edwards Lifesciences Corporation | $131.32 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $83.67 | 2020-2025 | Imfinzi |
| Smith+Nephew, INC. | $68.86 | 2022-2024 | Stravix, Grafix |
| Mallinckrodt Enterprises LLC | $52.96 | 2019 | |
| Innocoll Pharmaceuticals Limited | $47.80 | 2022 | |
| Advanced Accelerator Applications | $36.27 | 2019 | |
| Integra Lifesciences Corporation | $34.94 | 2021 | |
| Boston Scientific Corporation | $34.59 | 2020 | |
| Aroa Biosurgery Incorporated | $28.29 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $27.40 | 2019-2020 | |
| Angiodynamics, INC. | $23.09 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20.80 | 2019 | |
| Abbvie INC. | $18.17 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $18.03 | 2022 | |
| Amniox Medical, INC. | $17.86 | 2019 | |
| Ethicon US, LLC | $17.34 | 2019 | |
| Meditrina | $16.74 | 2023 | |
| Heron Therapeutics, INC. | $16.62 | 2022 | |
| Kci USA, INC. | $16.11 | 2023 | Prevena |
| Mallinckrodt Hospital Products INC. | $16.00 | 2020 | |
| Teleflex LLC | $15.72 | 2022 | |
| Solventum Corporation | $15.48 | 2025 | Activ.A.C., Prevena |
| Baxter Healthcare | $15.39 | 2022 | |
| Endogastric Solutions, INC | $14.94 | 2022 | |
| Conmed Corporation | $13.87 | 2025 | Airseal |
| Hydrofera LLC | $13.04 | 2023 | Hydrofera Blue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Schwab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.